Systematic Review of Motor Function Scales and Patient-Reported Outcomes in Spinal Muscular Atrophy
- PMID: 34483260
- DOI: 10.1097/PHM.0000000000001869
Systematic Review of Motor Function Scales and Patient-Reported Outcomes in Spinal Muscular Atrophy
Abstract
Spinal muscular atrophy is a heterogeneous disease that results in loss of motor function. In an evolving treatment landscape, establishing the suitability and limitations of existing motor function scales and patient-reported outcomes used to monitor patients with this disease is important. A systematic review was conducted to examine utility of motor function scales and patient-reported outcomes in evaluating patients with spinal muscular atrophy. Published literature was reviewed up to June 2021 with no start date restriction. Of the reports screened, 122 were deemed appropriate for inclusion and are discussed in this review (including 24 validation studies for motor function scales or patient-reported outcomes). Fifteen motor function scales and patient-reported outcomes were identified to be commonly used (≥5 studies), of which 11 had available validation assessments. Each instrument has its strengths and limitations. It is imperative that the patient population (e.g., age, mobility), goals of treatment, and outcomes or endpoints of interest be considered when selecting the appropriate motor function scales and patient-reported outcomes for clinical studies.
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.
References
-
- Crawford TO, Paushkin SV, Kobayashi DT, et al.: Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study. PLoS One 2012;7:e33572
-
- Nance JR: Spinal muscular atrophy. Continuum (Minneap Minn) 2020;26:1348–68
-
- Butchbach ME: Copy number variations in the survival motor neuron genes: implications for spinal muscular atrophy and other neurodegenerative diseases. Front Mol Biosci 2016;3:7
-
- Cho S, Dreyfuss G: A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev 2010;24:438–42
-
- Arnold WD, Kassar D, Kissel JT: Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve 2015;51:157–67
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical